350 related articles for article (PubMed ID: 27890442)
1. Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
Zahar JR; Lesprit P; Ruckly S; Eden A; Hikombo H; Bernard L; Harbarth S; Timsit JF; Brun-Buisson C;
Int J Antimicrob Agents; 2017 Jan; 49(1):67-73. PubMed ID: 27890442
[TBL] [Abstract][Full Text] [Related]
2. Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections.
Trecarichi EM; Cauda R; Tumbarello M
Future Microbiol; 2012 Oct; 7(10):1173-89. PubMed ID: 23030423
[TBL] [Abstract][Full Text] [Related]
3. Extended spectrum beta-lactamase producing Enterobacteriaceae causing bloodstream infections in rural Ghana, 2007-2012.
Eibach D; Belmar Campos C; Krumkamp R; Al-Emran HM; Dekker D; Boahen KG; Kreuels B; Adu-Sarkodie Y; Aepfelbacher M; Park SE; Panzner U; Marks F; May J
Int J Med Microbiol; 2016 Jun; 306(4):249-54. PubMed ID: 27222489
[TBL] [Abstract][Full Text] [Related]
4. Community-Onset Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Invasive Infections in Children in a University Hospital in France.
Toubiana J; Timsit S; Ferroni A; Grasseau M; Nassif X; Lortholary O; Zahar JR; Chalumeau M
Medicine (Baltimore); 2016 Mar; 95(12):e3163. PubMed ID: 27015202
[TBL] [Abstract][Full Text] [Related]
5. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
[TBL] [Abstract][Full Text] [Related]
6. Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis.
Rottier WC; Ammerlaan HS; Bonten MJ
J Antimicrob Chemother; 2012 Jun; 67(6):1311-20. PubMed ID: 22396430
[TBL] [Abstract][Full Text] [Related]
7. [Bacteraemia due to extended-spectrum beta-lactamases (ESBL) and other beta-lactamases (ampC and carbapenemase) producing Enterobacteriaceae: association with health-care and cancer].
García-Gómez M; Guío L; Hernández JL; Vilar B; Pijoán JI; Montejo JM
Rev Esp Quimioter; 2015 Oct; 28(5):256-62. PubMed ID: 26437756
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Kang CI; Song JH; Chung DR; Peck KR; Ko KS; Yeom JS; Ki HK; Son JS; Lee SS; Kim YS; Jung SI; Kim SW; Chang HH; Ryu SY; Kwon KT; Lee H; Moon C; Shin SY;
Int J Antimicrob Agents; 2010 Sep; 36(3):284-7. PubMed ID: 20580534
[TBL] [Abstract][Full Text] [Related]
9. Carriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study.
Pilmis B; Cattoir V; Lecointe D; Limelette A; Grall I; Mizrahi A; Marcade G; Poilane I; Guillard T; Bourgeois Nicolaos N; Zahar JR; Le Monnier A
J Hosp Infect; 2018 Mar; 98(3):247-252. PubMed ID: 29222035
[TBL] [Abstract][Full Text] [Related]
10. Propensity-matched analysis of the impact of extended-spectrum β-lactamase production on adults with community-onset Escherichia coli, Klebsiella species, and Proteus mirabilis bacteremia.
Lee CC; Lee CH; Hong MY; Hsieh CC; Tang HJ; Ko WC
J Microbiol Immunol Infect; 2018 Aug; 51(4):519-526. PubMed ID: 28698042
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and risk factors of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study.
Kung CH; Ku WW; Lee CH; Fung CP; Kuo SC; Chen TL; Lee YT
J Microbiol Immunol Infect; 2015 Apr; 48(2):168-74. PubMed ID: 24064292
[TBL] [Abstract][Full Text] [Related]
12. International travel is a risk factor for extended-spectrum β-lactamase-producing Enterobacteriaceae acquisition in children: A case-case-control study in an urban U.S. hospital.
Strysko JP; Mony V; Cleveland J; Siddiqui H; Homel P; Gagliardo C
Travel Med Infect Dis; 2016; 14(6):568-571. PubMed ID: 27890813
[TBL] [Abstract][Full Text] [Related]
13. Non-intravenous carbapenem-sparing antibiotics for definitive treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamase (ESBL) or AmpC β-lactamase: A propensity score study.
Meije Y; Pigrau C; Fernández-Hidalgo N; Clemente M; Ortega L; Sanz X; Loureiro-Amigo J; Sierra M; Ayestarán A; Morales-Cartagena A; Ribera A; Duarte A; Abelenda G; Rodríguez-Baño J; Martínez-Montauti J
Int J Antimicrob Agents; 2019 Aug; 54(2):189-196. PubMed ID: 31075401
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated from blood cultures in Africa.
Sangare SA; Maiga AI; Guindo I; Maiga A; Camara N; Savadogo S; Diallo S; Bougoudogo F; Armand-Lefevre L; Andremont A; Maiga II
Med Mal Infect; 2015 Sep; 45(9):374-82. PubMed ID: 26433872
[TBL] [Abstract][Full Text] [Related]
15. Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis.
Alevizakos M; Karanika S; Detsis M; Mylonakis E
Int J Antimicrob Agents; 2016 Dec; 48(6):647-654. PubMed ID: 27746102
[TBL] [Abstract][Full Text] [Related]
16. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
[TBL] [Abstract][Full Text] [Related]
17. Extended-Spectrum Beta Lactamase-producing Enterobacteriaceae among the pediatric population: who is at risk and why? Results from a single-centre prospective study.
Calitri C; Scolfaro C; Colombo S; De Intinis G; Carraro F; Garazzino S; Tovo PA
Infez Med; 2016 Dec; 24(4):318-325. PubMed ID: 28011968
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for colonization with extended-spectrum beta-lactamase-producing enterobacteriaceae on admission to rehabilitation centres.
Bilavsky E; Temkin E; Lerman Y; Rabinovich A; Salomon J; Lawrence C; Rossini A; Salvia A; Samso JV; Fierro J; Paul M; Hart J; Gniadkowski M; Hochman M; Kazma M; Klein A; Adler A; Schwaber MJ; Carmeli Y;
Clin Microbiol Infect; 2014 Nov; 20(11):O804-10. PubMed ID: 24674024
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
Nakai H; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Yamagishi Y; Mikamo H
J Infect Chemother; 2016 May; 22(5):319-26. PubMed ID: 26968486
[TBL] [Abstract][Full Text] [Related]
20. Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: an observational study.
Fennell J; Vellinga A; Hanahoe B; Morris D; Boyle F; Higgins F; Lyons M; O'Connell K; Keady D; Cormican M
BMC Infect Dis; 2012 May; 12():116. PubMed ID: 22587773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
